Date: 2015-12-17
Type of information: Nomination
Compound:
Company: Serodus (Norway)
Therapeutic area: Cardiovascular diseases
Type agreement: nomination
Action mechanism:
Disease: acute myocardial infarction
Details: * On December 17, 2015, Serodus announced the formation of a new Scientific Advisory Board for the development program in acute myocardial infarction (SER130).The appointed scientific advisors for the development program are: Prof. Dan Atar, MD, Oslo University Hospital, Oslo, Norway. Dr. Atar, is Head of Research at Oslo University Hospital Ulleval, Dept. of Mecidine, Oslo, Norway, and holds a full Professorship in Cardiology at the University of Oslo, Norway, along with a Visiting Associate Professorship at the Johns Hopkins Unversity, Baltimore, Maryland, USA. His research focuses on myocardial biomarkers, myocardial function, heart failure and cardiovascular pharmacology. Dr. A. Michael Lincoff, MD, Director, Center of Clinical Research and Vice Chairman for Clinical Research of the Lerner Research Institute, Cleveland, USA. Dr. Lincoff’s clinical research activities focus on development of therapies to reduce acute and long-term complications of percutaneous coronary revascularization procedures, to optimize therapy for acute coronary ischemic syndromes, or reduce progression or complications of atherosclerosis. He also oversees clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research and Vice Chairman for Clinical Research of the Lerner Research Institute. Prof. Hans Erik Bøtker Ph.D., MD., Aarhus University Hospital, Department of cardiology, Aarhus, Denmark. Dr. Bøtker is Professor of Cardiovascular Medicine and Interventional Cardiology and co-director of Department of Cardiology, Aarhus University Hospital Skejby, Denmark. He is past president of the Danish Society of Cardiology, advisor for the European Board for Accreditation in Cardiology (EBAC) and member of the Working Group of Coronary Pathology and Microcirculation in the European Society of Cardiology.
Financial terms:
Latest news:
